Manufacturers Life Insurance Company, The Igm Biosciences, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $103 Billion
- Q1 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 70,501 shares of IGMS stock, worth $454,731. This represents 0.0% of its overall portfolio holdings.
Number of Shares
70,501
Previous 48,942
44.05%
Holding current value
$454,731
Previous $406,000
67.49%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding IGMS
# of Institutions
89Shares Held
20.5MCall Options Held
11.1KPut Options Held
5.1K-
Baker Bros. Advisors LP New York, NY4.09MShares$26.4 Million0.5% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.89MShares$25.1 Million0.0% of portfolio
-
Artal Group S.A. Luxembourg, N43.08MShares$19.9 Million1.6% of portfolio
-
Redmile Group, LLC San Francisco, CA3.07MShares$19.8 Million1.17% of portfolio
-
Goldman Sachs Group Inc New York, NY1.28MShares$8.25 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $187M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...